Crossmark

α-NETA down-regulates CMKLR1 mRNA expression in ileum and prevents body weight gains collaborating with ERK inhibitor PD98059 in turn to alleviate hepatic steatosis in HFD-induced obese mice but no impact on ileal mucosal integrity and steatohepatitis progression

Crossref DOI link: https://doi.org/10.1186/s12902-023-01267-9

Published Online: 2023-01-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zheng, Canbin

Zheng, Yongping

Chen, Xi

Zhong, Xianyang

Zheng, Xiaobin

Yang, Shuhui

Zheng, Zihui
Funding

Funding for this research was provided by:

Guangdong medical research foundation (B2020007)

Guangdong medical research foundation (B2020007)

Guangdong medical research foundation (B2020007)

Guangdong medical research foundation (B2020007)

Guangdong medical research foundation (B2020007)

Guangdong medical research foundation (B2020007)
License Information

Text and Data Mining valid from 2023-01-10

Version of Record valid from 2023-01-10
More Information

Article History

Received: 14 October 2022

Accepted: 4 January 2023

First Online: 10 January 2023

Declarations

:

: This study was approved by Ethics Committee of Shantou Central Hospital (approval No: 2019–032). Protocols and all methods on the care and study of animals were performed in accordance with relevant guidelines and regulations. This study is reported in accordance with ARRIVE guidelines.

: Not required.

: The authors have declared no conflict of interest to report regarding the work presented in this manuscript.

Document is current

Any future updates will be listed below